The World Health Organization (WHO) estimates for the years 2007–2009, that globally almost 5%, of the world's population are carriers (i.e. heterozygous) of a potentially pathological Hb mutation (2.9% for thalassaemia and 2.3% for sickle cell disease). The gene discussed is GSTM1; the disease is thalassemia.